The National Lung Matrix Trial is the largest precision medicine trial in non-small cell lung cancer globally, testing a wide-range of therapies tailored specifically to target key genetic changes in cancer cells.
Find out more about the trial and how to get involved.
Find out more about the trial design and access our publications.
Access information for hospitals and download current trial documentation.
Stratified Medicine Programme 2
Cancer Research UK’s Stratified Medicine Programme 2 provides national genomic pre-screening for patients with Non-Small Cell Lung cancer, and is required to determine patient molecular eligibility for the National Lung Matrix Trial.
Find out more
Also in 'National Lung Matrix Trial'